Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

CNN anchor and reporter Jim Acosta is leaving the network, a significant departure by a media figure who was a top journalist at the cable channel during President Trump's first term in office. ...

The Hill - 3d

As Nvidia tanks, Jim Cramer says there's not enough information to make a move

CNBC's Jim Cramer reviewed Monday's market action as AI start-up DeepSeek disrupted the tech sector, sending market leader Nvidia into a tailspin.

CNBC - 4d

Here's what Jim Cramer tells investors to do with Nvidia as shares tumble on DeepSeek AI fears

AI chip king Nvidia is tumbling on the emergence of Chinese AI startup DeepSeek.

CNBC - 4d

Jim Cramer's top 10 things to watch in the stock market Monday

The emergence of Chinese AI startup DeepSeek is sending shockwaves on Wall Street.

CNBC - 4d

U.S. stock futures fall ahead of Fed meeting, key earnings week for Big Tech

U.S. stock futures sank Sunday night, ahead of a big week for Big Tech earnings and the Federal Reserve’s meeting.

MarketWatch - 5d

Here's what we'd like to see from our 8 stocks reporting earnings this week

Plus, we'll get the personal income and spending report, which includes the Fed's preferred measure of inflation.

CNBC - 5d

Jim Cramer's week ahead: Fed meeting and Big Tech earnings

CNBC's Jim Cramer highlighted what he's paying attention to next week as Wall Street launches into earnings season.

CNBC - Jan. 25

Jim Cramer's top 10 things to watch in the stock market Friday

Wall Street has a new favorite industrial growth stock. Plus, Novo Nordisk jumps on new obesity drug data.

CNBC - Jan. 24

Jim Cramer: Not all Trump comments are investing opportunities

CNBC's Jim Cramer on Thursday told investors that President Donald Trump's remarks, however highly-publicized, will not always yield solid investments.

CNBC - Jan. 23

Jim Cramer's top 10 things to watch in the stock market Thursday

Chip stocks fell in sympathy with SK Hynix. Shares of GE Aerospace jumped on earnings.

CNBC - Jan. 23

Jim Cramer predicts market action will reflect Trump instead of the Fed

CNBC's Jim Cramer on Wednesday told investors there will be a shift in Wall Street's focus.

CNBC - Jan. 22

Jim Cramer: Taiwan Semi's bullish earnings brings renewed optimism to broader sector

Jim Cramer reviewed the market reaction to TSMC's fourth quarter earnings report, with its profit rising 57% from a year earlier to a record high

CNBC - Jan. 22

Jim Cramer's top 10 things to watch in the stock market Wednesday

Wall Street was tracking for a higher open on strong earnings after the S&P 500 rose Tuesday for the fifth straight session.

CNBC - Jan. 22

Cramer's week ahead: Inauguration, earnings from Procter & Gamble and American Express

CNBC's Jim Cramer guided investors through next week on Wall Street, highlighting President-elect Donald Trump's inauguration.

CNBC - Jan. 17

The future of TikTok is cloudy, but Jim Cramer's advice for investors isn't

Whatever happens over the weekend, Jim is firm that Meta is a strong buy.

CNBC - Jan. 17

Jim Cramer says don't worry about falling CrowdStrike — and buy this evolving stock

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

CNBC - Jan. 17

Jim Cramer reflects on how the Biden administration might have affected the market

CNBC's Jim Cramer on Thursday mused about how President Joe Biden impacted the market.

CNBC - Jan. 16

Jim Cramer says to stay focused on earnings reports after Wednesday's stock rally

CNBC's Jim Cramer examined Wednesday's market rally and stressed that it's important to stay focused on corporate earnings and commentary from management.

CNBC - Jan. 15

Eli Lilly CEO expects new weight loss pill to be approved next year

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.

CNBC - Jan. 13

Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

CNBC - Jan. 13

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.

CNBC - Jan. 9

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.

MarketWatch - Jan. 9

Jim Cramer opines on TikTok ban: 'Let's just call it anybody’s ballgame'

CNBC's Jim Cramer on Wednesday gave investors his read on the future of TikTok.

CNBC - Jan. 8

Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise

Eli Lilly has been one of the worst-performing Club stocks over the past six months.

CNBC - Jan. 8

Struggling health stock perks up — and why Jim Cramer wants to buy more Disney

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

CNBC - Jan. 8

Jim Cramer's top 10 things to watch Wednesday — the special market froth edition

We're also watching jobs. Friday's employment report could determine whether Wall Street sees Fed rate cuts as appropriate or heavy-handed.

CNBC - Jan. 8

Jim Cramer says Nvidia's pullback could be a good chance to buy

CNBC's Jim Cramer extolled Nvidia's stock and reviewed its Tuesday action, saying the decline was unrelated to the company and its prospects.

CNBC - Jan. 8

Jim Cramer looks ahead to Friday's employment data: 'We’re at the mercy of macro numbers'

CNBC's Jim Cramer reviewed Tuesday's market-wide decline.

CNBC - Jan. 7

Jim Cramer's top 10 things to watch in the stock market Tuesday

Wall Street was looking at a muted open Tuesday after the S&P 500 and the Nasdaq closed higher for a second straight session

CNBC - Jan. 7

Jim Cramer explores why consumer goods stocks are seeing losses

CNBC's Jim Cramer reviewed Monday's market action and gave his take on why a large swath of stocks are notching losses.

CNBC - Jan. 6

Cramer's week ahead: nonfarm payrolls, PMI and earnings from Albertsons

CNBC's Jim Cramer on Friday walked investors through next week's market action.

CNBC - Jan. 3

How Jim Cramer views Corona brewer Constellation Brands after surgeon general warning

The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.

CNBC - Jan. 3

Jim Cramer's top 10 things to watch in the stock market Friday

Shipments from Tesla's Shanghai factory posted their first annual decline. A study on GLP-1 user behavior also caught my eye.

CNBC - Jan. 3

Latest in Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir

Topics